Article
Targeting lysosomal damage is a new therapeutic perspective for Duchenne Muscular Dystrophy
2025-02-13
Abstract excerpt
Duchenne Muscular Dystrophy (DMD), a muscle degenerative disease affecting young boys, arises from the loss of dystrophin. Current gene therapy approaches aim to restore a shortened form of dystrophin (microdystrophin) via Adeno-Associated Vector (AAV) delivery, but clinical studies show limited efficacy, emphasizing the need for improved strategies such as combined therapies. In this study, we identified lysosoma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9eecabd4-2b7e-5cf2-9a8d-5beabd018a4c
- DOI
- 10.1101/2025.02.11.637610
